Drug intelligence / Profile preview

Neurotec (Tehran University of Medical Sciences)

Development stage
Unknown
Lead developer
Tehran University of Medical Sciences
Administration
Oral
01

Overview

Neurotec is a herbal pharmaceutical product composed of extracts from *Rosa canina* (rosehip), *Tanacetum parthenium* (feverfew), and *Urtica dioica* (stinging nettle). Developed by researchers at the Tehran University of Medical Sciences, it is primarily indicated for the management of chronic inflammatory and pain conditions, including fibromyalgia and osteoarthritis. The drug exerts its therapeutic effects through a synergistic combination of anti-inflammatory and antioxidant mechanisms. Specifically, parthenolide from feverfew inhibits the NF-κB signaling pathway, thereby reducing the production of pro-inflammatory cytokines, while extracts from nettle and rosehip contribute to the inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. Clinical trials have demonstrated its efficacy in reducing pain scores and improving functional outcomes in patients with fibromyalgic disorder.

Brand names
Neurotec
Other names
Neurotec herbal capsule
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Neurotec (Tehran University of Medical Sciences).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurotec (Tehran University of Medical Sciences).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call